Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC

5th Mar 2021 11:54

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing04 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

1,801,156

1.40%

230,975

0.18%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

103,127

0.08%

7,066

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,910,383

1.48%

244,141

0.19%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit

Purchase

1

222.2400 USD

Purchase

1

222.0400 USD

Purchase

3

222.2266 USD

Purchase

3

221.9700 USD

Purchase

4

220.2200 USD

Purchase

4

222.1775 USD

Purchase

10

222.5500 USD

Purchase

11

222.9309 USD

Purchase

16

222.4500 USD

Purchase

26

222.1800 USD

Purchase

34

220.9800 USD

Purchase

48

221.9950 USD

Purchase

85

223.3800 USD

Purchase

100

222.4900 USD

Purchase

100

222.2500 USD

Purchase

200

222.3300 USD

Purchase

200

221.5325 USD

Purchase

200

222.9500 USD

Purchase

224

221.9511 USD

Purchase

244

221.0859 USD

Purchase

250

220.9250 USD

Purchase

259

221.7531 USD

Purchase

287

223.2266 USD

Purchase

425

221.4831 USD

Purchase

584

221.5876 USD

Purchase

1,258

221.8903 USD

Purchase

2,312

221.8267 USD

Purchase

3,900

220.3358 USD

Purchase

4,184

222.0434 USD

Purchase

4,471

222.0080 USD

Purchase

8,012

221.2278 USD

Purchase

9,791

222.0423 USD

Purchase

14,512

221.9340 USD

Purchase

28,557

222.1106 USD

Purchase

54,591

221.9500 USD

Sale

1

224.0500 USD

Sale

2

222.1750 USD

Sale

6

222.1100 USD

Sale

11

221.6600 USD

Sale

12

220.3400 USD

Sale

52

222.1800 USD

Sale

68

223.3447 USD

Sale

80

221.8410 USD

Sale

84

220.9800 USD

Sale

100

220.7300 USD

Sale

100

222.9500 USD

Sale

158

221.7601 USD

Sale

161

221.6849 USD

Sale

200

220.2600 USD

Sale

208

221.3697 USD

Sale

242

222.5122 USD

Sale

300

220.3033 USD

Sale

352

221.9576 USD

Sale

500

221.0984 USD

Sale

563

222.5650 USD

Sale

710

222.3112 USD

Sale

812

221.7177 USD

Sale

935

221.4445 USD

Sale

1,026

221.8391 USD

Sale

1,158

221.9905 USD

Sale

1,209

221.5418 USD

Sale

1,984

222.2813 USD

Sale

3,085

222.0947 USD

Sale

3,335

222.3353 USD

Sale

3,400

220.3431 USD

Sale

4,856

221.9500 USD

Sale

4,937

221.9242 USD

Sale

6,974

221.2372 USD

Sale

7,611

222.0136 USD

Sale

9,791

222.0423 USD

Sale

13,826

221.9606 USD

Sale

14,319

222.0980 USD

Sale

50,243

221.9502 USD

Sale

51,675

221.9459 USD

(b) Derivatives transactions (other than options transactions)

Product NameNature of transactionNumber of relevant securitiesPrice per
unit

SWAP

Long

71,000

221.9500 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:

5 Mar 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005242/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87